Coala-Life Group
Coala Life signs agreements for extended services for more than 40% of monitored patients (MFN)

2023-01-28 14:00

Coala Life announces today that it has signed renegotiated agreements that include 12 clinics and approx. 1,500 monitored patients regarding the company's expanded service for Managed RPM in the USA. Coala Life announced on December 13, 2022, that the expanded service means that the revenue per patient where the service is expanded will increase by about 50%.

” We have now for some weeks been in the process of signing agreements for the extended service with our affiliated clinics. Last night, Swedish time, renegotiated agreements covering 9 clinics were signed and previously renegotiated agreements have been signed with 3 clinics. The plan is for all patients to be connected during Q1 2023. Today's agreement shows that we are keeping a high pace in that process, which is very satisfying,” says Coala Life Group’s CEO Dan Pitulia.

The extended service includes more comprehensive analysis and reporting. Even including a certain strengthening of the company's qualified workforce, the increase in revenue is expected to lead to increased net margins. The extended service is basically based on the same agreement as before but with a revised and extended price list. The agreements began to be distributed and negotiated with affiliated clinics starting in January and discussions with all customers are underway, the plan is to conclude this process within Q1 2023.

About us

Coala-Life Group AB (“Coala Life” or the “Company”) founded in 2015, is a Cloud Based Software as a Service provider, and medical device developer and reseller, listed on Nasdaq First North Growth Market. The Company focuses on B2B solutions for managed Remote Patient Monitoring (“RPM”), offering medical care providers, primarily in the US, with a highly scalable, cost-efficient platform to remotely and virtually manage large volumes of patients suffering from chronic diseases. The company offers care providers a comprehensive solution and lifts the administrative work from the care providers regarding, amongst other things, follow-up, 24/7 monitoring, as well as the reimbursement process from state and private health insurance companies. Patients are monitored long-term in everyday life and typically have diabetes, obesity, and/or cardiovascular disease. 
For more information see

For more information, please contact:

Dan Pitulia, CEO Coala Life AB
+46 70 972 08 38,
Richard Roa, CFO Coala Life AB
+46 70 816 61 45,

Certified Adviser
The company's Certified Adviser is Erik Penser Bank AB.

This information is information that Coala Life is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-01-28 14:00 CET. (

Coala-life Group - I dag



Stockholmsbörsen, OMXS30

I dag


Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -


Valuta +/- % Senast


Ränta +/- % Senast
5-års ränta - -
10-års ränta - -


Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -